Trial intelligence / Profile preview

Fufang Biejia Ruangan Tablet in Hepatitis B-related Liver Fibrosis

NCT01965418Phase 4Unknown

Sponsor
The Fifth Medical Center of the PLA General Hospital
Start
Sep 2013
Primary completion
Dec 2015
Modality
HM (Herbal Medicine)
Countries
1
01

Overview

A Phase 4 trial of Fufang Biejia Ruangan in Liver Fibrosis (LF), Chronic Hepatitis B (CHB), sponsored by The Fifth Medical Center of the PLA General Hospital. Status: unknown.

02

Drugs

Fufang Biejia Ruangan
03

Conditions

Liver Fibrosis (LF)Chronic Hepatitis B (CHB)

Beyond the preview

Go deeper on NCT01965418.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01965418.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call